Enregistrement - Lobbyistes salariés d'entreprises

Objets

• Commerce intérieur
• Commerce international
• Environnement
• Impôts et finances
• Industrie
• Justice et application des lois
• Propriété intellectuelle
• Questions constitutionnelles
• Questions touchant les consommateurs
• Relations internationales
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Comprehensive Economic Trade Agreement (CETA) negotiations between Canada and European Union: Merck Canada seeking to ensure Canadian intellectual property protection for pharmaceuticals is harmonized with standards in EU to enable Canada to attract innovation.
• Drug Safety and Effectiveness Network (DSEN): Merck Canada seeking to work with DSEN to ensure Canadian standards for safety and effectiveness of drugs consistent with other jurisdictions.
• Health Canada's Blue Print for Renewal: Transforming Canada's Approach to Regulating Health Products and Food to renew the process for approving drugs. Merck Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
• Patented Medicine Prices Review Board (PMPRB) Pricing Guidelines used by the PMPRB to ensure that prices of patented medicines sold in Canada are not excessive. Merck Canada seeking to ensure PMPRB Guidelines reflect their mandate of ensuring prices are non-excessive, while ensuring an attractive climate for pharmaceutical research.
• The Government's Science and Technology (S&T) Strategy announced in May 2007 which encourages a more competitive Canadian economy and improved quality of life for Canadians through science and technology. Merck Canada seeking to ensure S&T Strategy encourages a more competitive environment for biopharmaceutical innovation in Canada.
• The National Pharmaceutical Strategy as agreed to by First Ministers in 2004, with a focus on options for catastrophic pharmaceutical coverage. Merck Canada seeking to ensure that Canadians' ability to access the medicines they need is increased.

Politique ou Programme, Règlement

• Canada's Access to Medicine Regime (CAMR) and its Regulations which provide a framework within which eligible developing countries can import less expensive generic versions of patented drugs and medical devices. Merck Canada seeking to ensure that those threatened by serious diseases have timely access to medicines for the diseases and that a research climate that will help to produce cures for other diseases is maintained. Canada's Access to Medicines Regime Regulations.

Proposition législative, Projet de loi ou résolution

• Canada's Food and Consumer Safety Action Plan proposes a series of initiatives to modernize and strengthen Canada's safety system for food, health and consumer products. Merck Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.

Règlement

• Health Canada Health Products and Foods Branch Cost Recovery Proposal for Human Drug User Fees. Merck Canada seeking to ensure that renewed user fees adequately fund a safe and efficient review process. Food and Drug Regulation.
• Patented Medicine Prices Review Board (PMPRB) Regulations identifying information to be reported to the PMPRB. Merck Canada seeking to ensure that the information being collected is consistent with PMPRB's mandate to prevent excessive pricing while ensuring an attractive climate for pharmaceutical research.
• Patented Medicines (Notice of Compliance) Regulations which seek to balance patent rights and cost savings. Merck Canada seeking to ensure that patent rights are respected and are internationally competitive.

Subvention, Contribution ou autre avantage financier

• National Immunization Strategy. Advocacy to seek continued funding in vaccines.

Techniques de communication

• Communication écrite
• Communication orale
• Appel au grand public

Institutions gouvernementales

• Affaires étrangères et Commerce international Canada (MAECIC)
• Agence canadienne de développement international (ACDI)
• Agence de la santé publique du Canada (ASPC)
• Bureau du Conseil privé (BCP)
• Bureau fédéral de développement régional (Québec) (BFDR[Q])
• Cabinet du Premier ministre (CPM)
• Commission de révision des marchés publics (CRMP)
• Condition féminine Canada (CFC)
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Conseil national de recherches (CNRC)
• Députés de la Chambre des communes
• Finances Canada (FIN)
• Industrie Canada
• Justice Canada (JC)
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Sécurité publique et Protection civile Canada (SPPCC)
• Sénat du Canada
• Solliciteur général Canada (SGC)
• Tribunal canadien du commerce extérieur (TCCE)

Adresse :
16711 TransCanada Highway
Kirkland, QC  H9H 3L1
Canada

Numéro de téléphone : 514-428-2638
Numéro de fax : 514-428-2662  

Renseignements sur la société mère